Phibro Animal Health Corporation
PAHC
$41.88
-$1.35-3.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.91% | 8.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.91% | 8.88% | |||
| Cost of Revenue | -10.05% | 13.63% | |||
| Gross Profit | 11.38% | -1.39% | |||
| SG&A Expenses | 5.85% | -3.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.50% | 10.51% | |||
| Operating Income | 28.20% | -3.81% | |||
| Income Before Tax | 52.08% | -19.67% | |||
| Income Tax Expenses | 47.06% | -24.81% | |||
| Earnings from Continuing Operations | 54.01% | -17.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.01% | -17.51% | |||
| EBIT | 28.20% | -3.81% | |||
| EBITDA | 25.64% | -6.00% | |||
| EPS Basic | 53.87% | -17.47% | |||
| Normalized Basic EPS | 19.81% | -21.07% | |||
| EPS Diluted | 52.83% | -16.61% | |||
| Normalized Diluted EPS | 19.42% | -21.10% | |||
| Average Basic Shares Outstanding | 0.08% | -0.05% | |||
| Average Diluted Shares Outstanding | 0.43% | -0.02% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.35% | 0.21% | |||